tiprankstipranks

Matthew Call Insider Profile

4 Followers
Matthew Call, COO at iTeos Therapeutics, holds 137.90K shares in iTeos Therapeutics (Ticker: ITOS).
tipranks
Matthew Call

Matthew Call
iTeos Therapeutics (ITOS)
COO

Ranked #47,223 out of 98,624 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+3.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
100.00%
A breakdown of Matthew Call's holdings

Insider Roles

iTeos Therapeutics
(ITOS)
COO
Roles that Matthew Call holds in companies

Most Profitable Insider Trade

Stock:
iTeos Therapeutics
(ITOS)
Rating:Informative Buy
Date:Aug 05, 2021 - Aug 05, 2022
Return:+8.90%
The most profitable trade made by Matthew Call

Matthew Call's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
iTeos Therapeutics
Dec 07, 2023
COO
Uninformative Buy
$1.48M
Success Rate for
ITOS
1 out of 2 profitable transactions on
ITOS
50%
Average Return for
ITOS
Average return per transaction on
ITOS
+3.45%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Dec 07, 2023
Uninformative Buy
$0.00
-
$0.00
Mar 29, 2023
Informative Buy
$118.67K
-
$2.95
-2.00%
Aug 05, 2021
Informative Buy
$158.33K
-
$2.95
+8.90%
List of latest transactions for each holding click on a transaction to see Matthew Call's performance on stock

Matthew Call insider profile FAQ

What is the percentage of profitable transactions made by Matthew Call?
The percentage of profitable transactions made by Matthew Call is 50%.
    What is the average return per transaction made by Matthew Call?
    The average return per transaction made by Matthew Call is 3.40%.
      What stocks does Matthew Call hold?
      Matthew Call holds: ITOS stocks.
        What was Matthew Call’s latest transaction?
        Matthew Call latest transaction was an Uninformative Buy of ―.
          What was Matthew Call's most profitable transaction?
          Matthew Call’s most profitable transaction was an Informative Buy of ITOS stock on August 5, 2021. The return on the trade was 8.90%.
            What is Matthew Call's role in iTeos Therapeutics?
            Matthew Call's role in iTeos Therapeutics is COO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.